128 related articles for article (PubMed ID: 20684568)
1. Targeted in-gel MRM: a hypothesis driven approach for colorectal cancer biomarker discovery in human feces.
Ang CS; Nice EC
J Proteome Res; 2010 Sep; 9(9):4346-55. PubMed ID: 20684568
[TBL] [Abstract][Full Text] [Related]
2. Use of multiple reaction monitoring for multiplex analysis of colorectal cancer-associated proteins in human feces.
Ang CS; Rothacker J; Patsiouras H; Gibbs P; Burgess AW; Nice EC
Electrophoresis; 2011 Aug; 32(15):1926-38. PubMed ID: 21538981
[TBL] [Abstract][Full Text] [Related]
3. Murine fecal proteomics: a model system for the detection of potential biomarkers for colorectal cancer.
Ang CS; Rothacker J; Patsiouras H; Burgess AW; Nice EC
J Chromatogr A; 2010 May; 1217(19):3330-40. PubMed ID: 19875126
[TBL] [Abstract][Full Text] [Related]
4. The discovery and validation of colorectal cancer biomarkers.
Ang CS; Phung J; Nice EC
Biomed Chromatogr; 2011 Jan; 25(1-2):82-99. PubMed ID: 21058408
[TBL] [Abstract][Full Text] [Related]
5. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
[TBL] [Abstract][Full Text] [Related]
6. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
7. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.
Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937
[TBL] [Abstract][Full Text] [Related]
8. Hyperplex-MRM: a hybrid multiple reaction monitoring method using mTRAQ/iTRAQ labeling for multiplex absolute quantification of human colorectal cancer biomarker.
Yin HR; Zhang L; Xie LQ; Huang LY; Xu Y; Cai SJ; Yang PY; Lu HJ
J Proteome Res; 2013 Sep; 12(9):3912-9. PubMed ID: 23909920
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive testing for colorectal cancer: a review.
Ouyang DL; Chen JJ; Getzenberg RH; Schoen RE
Am J Gastroenterol; 2005 Jun; 100(6):1393-403. PubMed ID: 15929776
[TBL] [Abstract][Full Text] [Related]
10. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
[TBL] [Abstract][Full Text] [Related]
11. [Fecal oncomarkers in the diagnostics of colorectal cancer].
Mikhaĭlova EI; Pimanov SI; Voropaev EV
Klin Med (Mosk); 2007; 85(12):62-7. PubMed ID: 18318171
[TBL] [Abstract][Full Text] [Related]
12. Detection of colorectal cancer cells from feces using quantitative real-time RT-PCR for colorectal cancer diagnosis.
Koga Y; Yasunaga M; Moriya Y; Akasu T; Fujita S; Yamamoto S; Kozu T; Baba H; Matsumura Y
Cancer Sci; 2008 Oct; 99(10):1977-83. PubMed ID: 19016757
[TBL] [Abstract][Full Text] [Related]
13. Improved fecal DNA test for colorectal cancer screening.
Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655
[TBL] [Abstract][Full Text] [Related]
14. Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer.
Zhao Y; Jia W; Sun W; Jin W; Guo L; Wei J; Ying W; Zhang Y; Xie Y; Jiang Y; He F; Qian X
J Proteome Res; 2010 Jun; 9(6):3319-27. PubMed ID: 20420461
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of an aberrant glycoform of TIMP1 from colon cancer serum by L-PHA-enrichment and SISCAPA with MRM mass spectrometry.
Ahn YH; Lee JY; Lee JY; Kim YS; Ko JH; Yoo JS
J Proteome Res; 2009 Sep; 8(9):4216-24. PubMed ID: 19645485
[TBL] [Abstract][Full Text] [Related]
16. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
[TBL] [Abstract][Full Text] [Related]
17. Stool test for colorectal cancer screening--it's time to move!
Loitsch SM; Shastri Y; Stein J
Clin Lab; 2008; 54(11-12):473-84. PubMed ID: 19216253
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial peptide libraries facilitate development of multiple reaction monitoring assays for low-abundance proteins.
Drabovich AP; Diamandis EP
J Proteome Res; 2010 Mar; 9(3):1236-45. PubMed ID: 20070123
[TBL] [Abstract][Full Text] [Related]
19. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
[TBL] [Abstract][Full Text] [Related]
20. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes.
Wu CC; Chen HC; Chen SJ; Liu HP; Hsieh YY; Yu CJ; Tang R; Hsieh LL; Yu JS; Chang YS
Proteomics; 2008 Jan; 8(2):316-32. PubMed ID: 18203259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
